WestVac Biopharma Co., Ltd., with a registered capital of 1.242 billion yuan, is a national high-tech enterprise that focuses on vaccine research, development, manufacturing and commercialization. Located in Chengdu Tianfu International Bio-town, the company is dedicated to developing and manufacturing innovative vaccines and immunotherapy products relying on five major technology platforms, including insect cell expression platform, mRNA vaccine platform, tumor vaccine platform, novel adjuvant platform and novel immunotherapy platform.
WestVac Biopharma has built up facilities for commercial production of vaccines in Chengdu compliant with GMP standards featuring optimal layout, scientific and safe production process and the equipment is basically made in China. WestVac has obtained the drug production license issued by the Sichuan Medical Products Administration. The company has an accomplished team with expertise in vaccine and biopharmaceutical product covering manufacturing, quality, operation and management. Solid production system and quality management system have been established to ensure large-scale production of vaccines.
